Published in Biometrics on December 01, 2003
Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med (2011) 19.42
Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial. BJOG (2015) 1.46
Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes (2010) 1.10
African American men's and women's perceptions of clinical trials research: focusing on prostate cancer among a high-risk population in the South. J Health Care Poor Underserved (2013) 1.03
Ductal lavage is an inefficient method of biomarker measurement in high-risk women. Cancer Prev Res (Phila) (2009) 0.95
An extension of the Wilcoxon Rank-Sum test for complex sample survey data. J R Stat Soc Ser C Appl Stat (2012) 0.88
Methods for sample size determination in cluster randomized trials. Int J Epidemiol (2015) 0.85
A General Class of Signed Rank Tests for Clustered Data when the Cluster Size is Potentially Informative. J Nonparametr Stat (2012) 0.85
A rank-sum test for clustered data when the number of subjects in a group within a cluster is informative. Biometrics (2015) 0.82
Development and Validation of a Prediction Model for Admission After Endoscopic Retrograde Cholangiopancreatography. Clin Gastroenterol Hepatol (2015) 0.78
Power and sample size estimation for the clustered wilcoxon test. Biometrics (2010) 0.77
Personalized Identification of Differentially Expressed Modules in Osteosarcoma. Med Sci Monit (2017) 0.75
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J (2007) 3.21
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation (2013) 3.03
Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73
The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42
Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol (2002) 2.09
C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol (2004) 2.08
A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes (2004) 2.03
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation (2005) 2.02
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf (2006) 1.99
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ (2002) 1.99
Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation (2009) 1.97
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum (2006) 1.94
The effect of cigarette smoking on gingival bleeding. J Periodontol (2004) 1.91
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation (2006) 1.85
A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol (2005) 1.83
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med (2002) 1.82
One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf (2012) 1.82
Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf (2012) 1.81
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int (2003) 1.80
Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med (2004) 1.79
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making (2002) 1.78
Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J (2008) 1.78
Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension (2005) 1.77
Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77
Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med (2004) 1.76
The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf (2011) 1.74
Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol (2008) 1.74
Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol (2002) 1.73
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol (2009) 1.73
Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation (2007) 1.72
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72
Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J (2009) 1.69
Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model. Stat Med (2003) 1.68
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol (2010) 1.67
Burden of smoking on cause-specific mortality: application to the Nurses' Health Study. Tob Control (2010) 1.67
Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data. Cancer Causes Control (2007) 1.66
Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications. Med Care (2009) 1.62
Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology (2009) 1.62
Risk factors for mortality in the nurses' health study: a competing risks analysis. Am J Epidemiol (2010) 1.61
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. Am Heart J (2013) 1.60
Alcohol consumption and plasma concentration of C-reactive protein. Circulation (2003) 1.60
Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol (2010) 1.60
Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol (2008) 1.59
Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol (2013) 1.57
Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol (2009) 1.56
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care (2007) 1.56
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. J Am Coll Cardiol (2011) 1.55
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther (2006) 1.55
The cross-sectional cohort study: an underutilized design. Epidemiology (2005) 1.55
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med (2003) 1.53